Claim
descriptive

When injections of GIP(3-42) were stopped in diabetic mice, their improved blood sugar control and insulin sensitivity returned to their original levels within two weeks.

Evidence from Studies

No evidence studies found yet.

What Would Prove This

Per GRADE and EBM methodology, here is what ideal scientific evidence would look like to definitively prove or disprove this claim, ordered from strongest to weakest.

1
Systematic Reviews & Meta-Analyses

Whether metabolic effects of GIP(3-42) are consistently reversible across animal models after treatment cessation.

A systematic review and meta-analysis of all studies reporting metabolic outcomes (glucose, insulin sensitivity) before, during, and after GIP(3-42) withdrawal in diabetic rodent models, with standardized timeframes and effect sizes.

2
Randomized Controlled Trials

Whether GIP(3-42) withdrawal causes a statistically significant return to baseline insulin sensitivity in diabetic mice.

A double-blind, randomized trial in 50 ob/ob mice, randomized to receive GIP(3-42) for 14 days followed by saline for 14 days (n=25) or saline for 28 days (n=25), with insulin sensitivity measured by clamp at baseline, day 14, and day 28 as primary endpoint.

3
Cohort Studies

Whether the rate of metabolic decline after GIP(3-42) cessation correlates with baseline insulin sensitivity or peptide half-life.

A longitudinal cohort study in 60 ob/ob mice receiving GIP(3-42) for 14 days, then monitored daily for glucose and insulin sensitivity for 21 days after cessation, with plasma peptide levels measured at intervals.

4
Case-Control Studies

Whether mice with the fastest metabolic rebound after GIP(3-42) cessation have different baseline metabolic profiles than those with slow rebound.

A case-control study comparing baseline insulin sensitivity and plasma GIP(3-42) clearance rates in 20 mice with rapid metabolic rebound (return to baseline in <7 days) versus 20 with slow rebound (>14 days) after treatment cessation.

5
Cross-Sectional Studies

Whether insulin sensitivity at 14 days post-cessation correlates with duration of prior GIP(3-42) exposure.

A cross-sectional analysis of insulin sensitivity in 60 ob/ob mice at 14 days after cessation of GIP(3-42), grouped by prior exposure duration (7, 14, 21 days), with no intervention during washout.

Sign up to see full verdict